NICE guidelines for kidney cancer

Share this page:

The National Institute for health and Care Excellence (NICE) has compiled clinical guidelines to provide clinicians with evidence-based information and recommendations for the management of spinal metastases and spinal cord compression as a result of metastases from cancer.

It must be emphasised that clinical guidelines present the best evidence available to the experts, but following guideline recommendations will not necessarily result in the best outcome. Guidelines can never replace clinical expertise when making treatment decisions for individual patients. However, they can help to focus decisions taking personal values, preferences, and individual circumstances into account.

Read the information for the public on the NICE guideline for spinal metastases and metastatic spinal cord compression here.  Read the full NICE guidance here. These guidelines were published on 6 September 2023. Here is a pdf version of the guidance: Guidance for spinal metastases and metastatic spinal cord compression

Please note, these guidelines have been written for urologists and oncologists, and the terminology used is not patient-friendly. If you need clarification of these guidelines, please get in touch with us by email. Talk to your doctor or your hospital team about any concerns or issues that you have about the way your kidney cancer is being managed.

NICE are currently in the process of producing guidelines for the management of kidney cancer. These will be available on the NICE website in 2025.

Share this page: